• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future.2 型糖尿病的病理生理学和治疗:过去、现在和未来的观点。
Lancet. 2014 Mar 22;383(9922):1068-83. doi: 10.1016/S0140-6736(13)62154-6. Epub 2013 Dec 3.
2
[And what about diabetes?].那糖尿病呢?
Bull Acad Natl Med. 2007 Apr-May;191(4-5):941-3; discussion 943.
3
Development and characterization of a novel rat model of type 2 diabetes mellitus: the UC Davis type 2 diabetes mellitus UCD-T2DM rat.一种新型2型糖尿病大鼠模型的建立与特性研究:加州大学戴维斯分校2型糖尿病UCD-T2DM大鼠
Am J Physiol Regul Integr Comp Physiol. 2008 Dec;295(6):R1782-93. doi: 10.1152/ajpregu.90635.2008. Epub 2008 Oct 1.
4
A surrogate of Roux-en-Y gastric bypass (the enterogastro anastomosis surgery) regulates multiple beta-cell pathways during resolution of diabetes in ob/ob mice.Roux-en-Y 胃旁路术(肠胃吻合术)的替代物在 ob/ob 小鼠糖尿病缓解过程中调节多种β细胞通路。
EBioMedicine. 2020 Aug;58:102895. doi: 10.1016/j.ebiom.2020.102895. Epub 2020 Jul 30.
5
Protection of pancreatic beta-cells: is it feasible?保护胰腺β细胞:可行吗?
Nutr Metab Cardiovasc Dis. 2008 Jan;18(1):74-83. doi: 10.1016/j.numecd.2007.05.004.
6
Fate of the beta-cell in the pathophysiology of type 2 diabetes.2型糖尿病病理生理学中β细胞的命运
J Am Pharm Assoc (2003). 2009 Sep-Oct;49 Suppl 1:S10-5. doi: 10.1331/JAPhA.2009.09076.
7
Increased β-Cell Mass in Obese Rats after Gastric Bypass: A Potential Mechanism for Improving Glycemic Control.胃旁路术后肥胖大鼠β细胞量增加:改善血糖控制的潜在机制
Med Sci Monit. 2017 May 6;23:2151-2158. doi: 10.12659/msm.902230.
8
Over-nutrition, obesity and insulin resistance in the development of β-cell dysfunction.营养过剩、肥胖与胰岛素抵抗在β细胞功能障碍发生发展中的作用
Curr Diabetes Rev. 2012 Mar;8(2):76-83. doi: 10.2174/157339912799424564.
9
Preservation of β-Cells as a Therapeutic Strategy for Diabetes.β细胞保护作为糖尿病治疗策略。
Horm Metab Res. 2024 Apr;56(4):261-271. doi: 10.1055/a-2239-2668. Epub 2024 Feb 22.
10
Surgical treatment of obesity: impact on diabetes and other comorbidities.肥胖症的外科治疗:对糖尿病及其他合并症的影响
Nutr Metab Cardiovasc Dis. 2008 Jan;18(1):1-6. doi: 10.1016/j.numecd.2006.12.004. Epub 2007 Apr 30.

引用本文的文献

1
Multi-omics investigation of spontaneous T2DM macaque emphasizes gut microbiota could up-regulate the absorption of excess palmitic acid in the T2DM progression.自发性2型糖尿病猕猴的多组学研究强调,肠道微生物群可能在2型糖尿病进展过程中上调过量棕榈酸的吸收。
Elife. 2025 Aug 29;14:RP104355. doi: 10.7554/eLife.104355.
2
Screening and Assessment of Hypoglycemic Active Peptide from Natural Edible Pigment Phycobiliprotein Based on Molecular Docking, Network Pharmacology, Enzyme Inhibition Assay Analyses, and Cell Experiments.基于分子对接、网络药理学、酶抑制试验分析及细胞实验对天然食用色素藻胆蛋白中降血糖活性肽的筛选与评估
Mar Drugs. 2025 Aug 17;23(8):331. doi: 10.3390/md23080331.
3
Economic evaluation of liraglutide vs dulaglutide or oral semaglutide in patients with type 2 diabetes mellitus: a systematic review.利拉鲁肽与度拉鲁肽或口服司美格鲁肽治疗2型糖尿病患者的经济学评价:一项系统评价
Diabetol Metab Syndr. 2025 Aug 27;17(1):358. doi: 10.1186/s13098-025-01927-x.
4
Emergency risk stratification using the TyG index: a multi-center cohort study on nonlinear association with 28-day mortality among critically ill patients transferred from the ED to the ICU.使用TyG指数进行急诊风险分层:一项关于从急诊科转入重症监护病房的危重症患者28天死亡率的非线性关联的多中心队列研究。
Front Med (Lausanne). 2025 Jul 30;12:1605843. doi: 10.3389/fmed.2025.1605843. eCollection 2025.
5
The Inflammatory Bridge Between Type 2 Diabetes and Neurodegeneration: A Molecular Perspective.2型糖尿病与神经退行性变之间的炎症桥梁:分子视角
Int J Mol Sci. 2025 Aug 5;26(15):7566. doi: 10.3390/ijms26157566.
6
Allogenic Mitochondria and Associated Organelle Complex Treatment Attenuates High-Fat Diet-Induced Adipose Tissue Remodeling.同种异体线粒体及相关细胞器复合体治疗可减轻高脂饮食诱导的脂肪组织重塑。
Circ Rep. 2025 Jun 28;7(8):661-669. doi: 10.1253/circrep.CR-25-0045. eCollection 2025 Aug 8.
7
Noninvasive On-Skin Biosensors for Monitoring Diabetes Mellitus.用于监测糖尿病的无创皮肤生物传感器
Nanomicro Lett. 2025 Jul 31;18(1):16. doi: 10.1007/s40820-025-01843-9.
8
Sodium-glucose co-transporter 2 inhibitors improve insulin resistance and β-cell function in type 2 diabetes: A meta-analysis.钠-葡萄糖协同转运蛋白2抑制剂改善2型糖尿病患者的胰岛素抵抗和β细胞功能:一项荟萃分析。
World J Diabetes. 2025 Jul 15;16(7):107335. doi: 10.4239/wjd.v16.i7.107335.
9
Increased Glycemic Variability in Patients With Chronic Pancreatitis and Diabetes Compared to Type 2 Diabetes.与2型糖尿病相比,慢性胰腺炎合并糖尿病患者的血糖变异性增加。
J Diabetes Sci Technol. 2025 Jul 18:19322968251356239. doi: 10.1177/19322968251356239.
10
Parabacteroides as a promising target for disease intervention: current stage and pending issues.副拟杆菌作为疾病干预的一个有前景的靶点:现状与待解决问题
NPJ Biofilms Microbiomes. 2025 Jul 19;11(1):137. doi: 10.1038/s41522-025-00772-0.

本文引用的文献

1
Diabetes mellitus: its differentiation into insulin-sensitive and insulin-insensitive types. 1936.糖尿病:分为胰岛素敏感型和胰岛素不敏感型。1936年。
Int J Epidemiol. 2013 Dec;42(6):1594-8. doi: 10.1093/ije/dyt203.
2
Sodium-glucose cotransporter 2 inhibitors for type 2 diabetes: a systematic review and meta-analysis.钠-葡萄糖共转运蛋白 2 抑制剂治疗 2 型糖尿病:系统评价和荟萃分析。
Ann Intern Med. 2013 Aug 20;159(4):262-74. doi: 10.7326/0003-4819-159-4-201308200-00007.
3
Alogliptin after acute coronary syndrome in patients with type 2 diabetes.阿格列汀治疗 2 型糖尿病合并急性冠脉综合征患者。
N Engl J Med. 2013 Oct 3;369(14):1327-35. doi: 10.1056/NEJMoa1305889. Epub 2013 Sep 2.
4
Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.沙格列汀与 2 型糖尿病患者的心血管结局。
N Engl J Med. 2013 Oct 3;369(14):1317-26. doi: 10.1056/NEJMoa1307684. Epub 2013 Sep 2.
5
Reprogramming of intestinal glucose metabolism and glycemic control in rats after gastric bypass.胃旁路手术后大鼠肠道葡萄糖代谢和血糖控制的重编程。
Science. 2013 Jul 26;341(6144):406-10. doi: 10.1126/science.1235103.
6
Diabetes: glycaemic control in type 2 (drug treatments).糖尿病:2型糖尿病的血糖控制(药物治疗)
BMJ Clin Evid. 2012 Oct 11;2012:0609.
7
LY2405319, an Engineered FGF21 Variant, Improves the Metabolic Status of Diabetic Monkeys.LY2405319,一种工程化的成纤维细胞生长因子21变体,可改善糖尿病猴的代谢状况。
PLoS One. 2013 Jun 18;8(6):e65763. doi: 10.1371/journal.pone.0065763. Print 2013.
8
Salicylate (salsalate) in patients with type 2 diabetes: a randomized trial.水杨酸盐(柳氮磺胺吡啶)治疗 2 型糖尿病患者:一项随机试验。
Ann Intern Med. 2013 Jul 2;159(1):1-12. doi: 10.7326/0003-4819-159-1-201307020-00003.
9
Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes.2 型糖尿病强化生活方式干预的心血管效应。
N Engl J Med. 2013 Jul 11;369(2):145-54. doi: 10.1056/NEJMoa1212914. Epub 2013 Jun 24.
10
Effects of chenodeoxycholic acid on the secretion of gut peptides and fibroblast growth factors in healthy humans.鹅去氧胆酸对健康人体肠道肽和成纤维细胞生长因子分泌的影响。
J Clin Endocrinol Metab. 2013 Aug;98(8):3351-8. doi: 10.1210/jc.2012-4109. Epub 2013 Jun 19.

2 型糖尿病的病理生理学和治疗:过去、现在和未来的观点。

Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future.

机构信息

Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, VA Puget Sound Health Care System, University of Washington, Seattle, WA, USA.

Diabetes Division, Baker IDI Heart and Diabetes Institute, Melbourne, VIC, Australia.

出版信息

Lancet. 2014 Mar 22;383(9922):1068-83. doi: 10.1016/S0140-6736(13)62154-6. Epub 2013 Dec 3.

DOI:10.1016/S0140-6736(13)62154-6
PMID:24315620
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4226760/
Abstract

Glucose metabolism is normally regulated by a feedback loop including islet β cells and insulin-sensitive tissues, in which tissue sensitivity to insulin affects magnitude of β-cell response. If insulin resistance is present, β cells maintain normal glucose tolerance by increasing insulin output. Only when β cells cannot release sufficient insulin in the presence of insulin resistance do glucose concentrations rise. Although β-cell dysfunction has a clear genetic component, environmental changes play an essential part. Modern research approaches have helped to establish the important role that hexoses, aminoacids, and fatty acids have in insulin resistance and β-cell dysfunction, and the potential role of changes in the microbiome. Several new approaches for treatment have been developed, but more effective therapies to slow progressive loss of β-cell function are needed. Recent findings from clinical trials provide important information about methods to prevent and treat type 2 diabetes and some of the adverse effects of these interventions. However, additional long-term studies of drugs and bariatric surgery are needed to identify new ways to prevent and treat type 2 diabetes and thereby reduce the harmful effects of this disease.

摘要

葡萄糖代谢通常受到一个反馈回路的调节,其中包括胰岛β细胞和胰岛素敏感组织,在这个回路中,组织对胰岛素的敏感性会影响β细胞反应的程度。如果存在胰岛素抵抗,β细胞通过增加胰岛素分泌来维持正常的葡萄糖耐量。只有当β细胞在存在胰岛素抵抗的情况下无法释放足够的胰岛素时,血糖浓度才会升高。尽管β细胞功能障碍有明显的遗传成分,但环境变化也起着至关重要的作用。现代研究方法有助于确定己糖、氨基酸和脂肪酸在胰岛素抵抗和β细胞功能障碍中的重要作用,以及微生物组变化的潜在作用。已经开发出几种新的治疗方法,但需要更有效的疗法来减缓β细胞功能的进行性丧失。临床试验的最新发现提供了有关预防和治疗 2 型糖尿病的方法的重要信息,以及这些干预措施的一些不良反应。然而,需要进行更多的长期药物和减肥手术研究,以确定预防和治疗 2 型糖尿病的新方法,从而减少这种疾病的有害影响。